← Eichor
Condition: Herpes Zoster Hz Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Herpes Zoster Hz

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Evaluate the Safety of Recombinant Herpes Zoster Vaccine for Healthy Individuals
Phase 1/Phase 2 · 1 location(s) · Shanghai Institute Of Biological Products · NCT06932523A Study That Collects Participant Data and Biospecimens to Analyze Pathogenic Exosomes That Mediate Increased Vascular D
Phase N/A · 2 location(s) · Center for Clinical Studies, Texas · NCT06903078Comparative Efficacy of Pregabalin and Lacosamide in Patients With Herpes Zoster and Post Herpetic Neuralgia
NA · 1 location(s) · CMH Kharian Medical College · NCT06969417Safety and Immunogenicity of the Recombinant Zoster Vaccine, LYB004 in Adults Aged 40 Years and Older
Phase 1 · 1 location(s) · Guangzhou Patronus Biotech Co., Ltd. · NCT06874842Clinical Study on the Treatment of Herpes Zoster Pain With Dexmedetomidine Combined With Long-term High Voltage
Phase 2 · 1 location(s) · Fenghui Deng · NCT06978192A Study to Test GlaxoSmithKline's (GSK) Candidate Vaccine-GSK1437173A for Prevention of Shingles in Children With Kidney
Phase 1/Phase 2 · 31 location(s) · GlaxoSmithKline · NCT04006808Reduced Vaccine Response to HZ/su in SLE
Phase N/A · 1 location(s) · Seoul National University Hospital · NCT07636044Shingrix in Renal Transplant Recipients
Phase 3 · 4 location(s) · University of Colorado, Denver · NCT04128189
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.